Case Studies
March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy
Patient Engagement
Pharma
Case Studies
March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity
Pharma
Rare Disease
Articles
February 17, 2025
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.
Patient Centricity
Pharma
Rare Disease
Articles
February 11, 2025
From Diagnosis to Long-Term Care: Navigating the Rare Disease Journey
For Rare Disease Day, we spoke with patient engagement expert Luca Trentin on challenges faced by rare disease patients and how pharma can better understand their needs.
Patient Centricity
Pharma
Rare Disease
Articles
December 10, 2024
2024 Antibody-Drug Conjugates Landscape: Market Expansion, Innovations, and Strategic Acquisitions
Antibody-Drug Conjugates (ADCs) have emerged as a groundbreaking strategy in precision oncology, uniquely merging the specificity of antibodies with the potency of cytotoxic drugs.
ADC
Antibody-Drug Conjugates
Pharma
News
December 2, 2024
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
This in-depth report explores emerging trends, competitive dynamics, market opportunities, cutting-edge innovations, and pivotal transactions shaping the antibody-drug conjugates (ADC) market.
ADC
Antibody-Drug Conjugates
Pharma
